AIM ImmunoTech, Inc. (AIM) - Yalpi foyda normasi

AIM (AIM ImmunoTech, Inc.) - kompaniyaning tovar belgisi

AIM ImmunoTech onkologiya va viruslarga qarshi kurashish uchun ilg'or davolash usullarini ishlab chiqmoqda hamda o'zining asosiy dori nomzodini ro'yxatdan o'tkazishdagi murakkabliklarni bartaraf etmoqda. Valo martaba daromadliligi ishlab chiqarish xarajatlaridan keyingi foyda dinamikasini aks ettiradi, bunda -945.00 belgisi ushbu parametrni tavsiflaydi. Biznes barqarorligi US shartnomaviy qadoqlash hamkorlari bilan uzoq muddatli quvvat rezervatsiyalari orqali ta'minlanadi.

AIM AIM ImmunoTech Yalpi rentabellik (04.07.2022 - 19.11.2026)

AIM ImmunoTech, Inc. (AIM) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
Kompaniyaning asosiy tahlili:AIM ImmunoTech, Inc.
AIM ImmunoTech Inc. asosiy tovari

Onkologiya sohasida Ampligen dori vositasini kengaytirish yuqori xarajatlar samaradorligini talab qiladi, bu esa AIM ImmunoTech (AIM) uchun yalpi foyda marjasini operatsion samaradorlikning asosiy ko'rsatkichiga aylantiradi. Ushbu metrika tushumning bevosita ishlab chiqarish xarajatlari chegirib tashlangan qismi sifatida hisoblanadi va biznesning ma'muriy xarajatlar hisobga olinishidan oldin foyda keltirish qobiliyatini belgilaydi. Yalpi foyda marjasi tendentsiyalarini tahlil qilish investorlarga biznes modelining barqarorligini baholash va aktiv uchun haddan tashqari ko'p to'lov qilishdan qochish imkonini beradi.

Asosiy raqobatchilar

argenx - Yalpi foyda normasi|Yalpi rentabellik biontech.de|ABIVAX (ABVX) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja ADMA|Yalpi foyda koeffitsiyenti PTGX|Yalpi rentabellik Immunovant Corp IMVT|Yalpi marja Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Yalpi foyda bo'yicha rentabellik|Aurinia Pharmaceuticals Inc. (AUPH) - Yalpi marja|Yalpi foyda bo'yicha rentabellik BCRX|Yalpi foyda marjasi Vera Therapeutics Inc VERA|Yalpi foyda bo'yicha rentabellik DNTH (Dianthus Pharma)|Yalpi foyda bo'yicha sotuv rentabelligi Pharvaris N.V.|AbCellera Biologics Inc - Yalpi foyda bo'yicha rentabellik|Tourmaline Bio (TRML) - Yalpi foyda marjasi|PGEN - Yalpi rentabellik|Yalpi foyda normasi PHAR (Pharming Group NV)|NKTR: Yalpi marja|Upstream Bio Corp - Yalpi foyda normasi|Yalpi rentabellik Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOSS|Yalpi foyda bo'yicha rentabellik KalVista Pharmaceuticals, Inc. KALV|Yalpi rentabellik Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Yalpi foyda marjasi|SVRA - Yalpi rentabellik|Rigel Pharmaceuticals - Yalpi foyda koeffitsiyenti|AnaptysBio Corp (ANAB) - Yalpi rentabellik|ATXS - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik enGene Holdings Inc.|RAPT: Yalpi foyda normasi|Yalpi marja JBIO|Yalpi foyda bo'yicha rentabellik aclaristx.com ACRS|Yalpi rentabellik Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Yalpi foyda marjasi|Cabaletta Bio, Inc - Yalpi marja|Yalpi foyda marjasi Ventyx Biosciences|THTX (theratech.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Yalpi marja|Yalpi foyda marjasi Agenus Inc. AGEN|Yalpi foyda bo'yicha rentabellik CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Yalpi foyda normasi|Yalpi rentabellik atyrpharma.com ATYR|Yalpi marja Adagene Corp ADAG|IMA - Yalpi rentabellik|Yalpi foyda normasi STTK (Shattuck Labs)|EQ: Yalpi marja|Connect Biopharma (CNTB) - Yalpi marja|Yalpi rentabellik Immunic|Yalpi marja atarabio.com|Yalpi marja IFRX|Yalpi marja X4 Pharma (XFOR)|Yalpi marja ACET (adicetbio.com)|Yalpi marja Celularity Inc. CELU|INMB - Yalpi rentabellik|Yalpi foyda normasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik SAB Biotherapeutics Inc.|Yalpi foyda bo'yicha rentabellik AKTX|Yalpi foyda bo'yicha rentabellik enlivex.com (ENLV)|Yalpi rentabellik Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Sotuvning yalpi marjinal rentabelligi|Yalpi marja EDSA (Edesa Biotech Corp)|Yalpi foyda bo'yicha sotuv rentabelligi iBio (IBIO)|CARM - Yalpi rentabellik|XTL Biopharmaceuticals (XTLB) - Yalpi foyda bo'yicha rentabellik|BOLT: Yalpi marja|Yalpi foyda bo'yicha rentabellik HCW Biologics Inc.|Yalpi rentabellik Aptevo|Yalpi foyda bo'yicha rentabellik Aditxt (ADTX)|Yalpi foyda bo'yicha rentabellik GRI (GRI Bio Corporation)|XORTX - Sotuvning yalpi rentabelligi|Yalpi marja HIND (Vyome Holdings Inc.)|Yalpi foyda normasi REVB|Indaptus - Yalpi marja|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning yalpi rentabelligi|CALI: Yalpi marja|Affimed NV - Yalpi foyda normasi|Yalpi rentabellik Allakos Inc.|Yalpi marja HOOKIPA Pharma|Yalpi rentabellik IGM Biosciences, Inc. (IGMS)|ITOS - Yalpi foyda marjasi|Yalpi marja OCEA (Ocean Bio)|Yalpi foyda normasi TCBP|THRD - Yalpi rentabellik